Vendor, Royal Oak, MI
William Beaumont Hospital
UEI KJWYBQN9STL7, CAGE 1KFL4
1 award and -$14,590 obligated between June 12, 2024 and June 12, 2024, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 | -$14,590 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Delivery Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91019F00129Delivery Order, June 12, 2024, Competed Under SAP, 1 offers | NIH NCINational Institutes of Health | Beaumont William Hospital:1107346 [19-029098] Tissue Source Site (Tss)for Nci'S Clinical Proteomic Tumor Analysis Consortium Cptac) Cases ElNAICS 325413, PSC 6550 | -$14,590 |
- Places of performance
- Michigan
- Product and service codes
- 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
- Transactions
- 1 across 1 awards